| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.9M | +32.8% |
| SG&A Expense | $2.1M | +54.8% |
| Operating Income | -$4.8M | -29.6% |
| Pre-tax Income | $4.7M | +227.4% |
| Net Income | -$4.7M | -27.4% |
| EPS (Basic) | -$0.07 | -16.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.0M | +6.6% |
| Accounts Receivable | $55K | -17.9% |
| Current Assets | $3.1M | +6.1% |
| Total Assets | $3.3M | +11.9% |
| Current Liabilities | $662K | +67.6% |
| Long-term Debt | $40K | — |
| Total Liabilities | $702K | +22.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.4M | -36.0% |
| Capital Expenditures | $50K | +61.3% |
| Investing Cash Flow | -$59K | +3.3% |
| Financing Cash Flow | $3.6M | +3.8% |
| Free Cash Flow | -$3.4M | -36.3% |
| Stockholders' Equity |
| $2.6M |
| +9.3% |